These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29772361)

  • 1. Comparative Histologic and Molecular Analysis of 2 Recurrent Lesions Showing Different Magnetic Resonance Imaging Responses After Bevacizumab Treatment: Report of a Case of Anaplastic Astrocytoma.
    Otani Y; Ichikawa T; Uneda A; Kurozumi K; Ishida J; Date I
    World Neurosurg; 2018 Aug; 116():464-471.e1. PubMed ID: 29772361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusely Infiltrating Cerebellar Anaplastic Astrocytoma Effectively Controlled with Bevacizumab: Case Report and Literature Review.
    Kohzuki H; Matsuda M; Miki S; Shibuya M; Ishikawa E; Matsumura A
    World Neurosurg; 2018 Jul; 115():181-185. PubMed ID: 29704688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma multiforme versus pleomorphic xanthoastrocytoma with anaplastic features in the pathological diagnosis: a case report.
    Yamada SM; Murakami H; Tomita Y; Nakane M; Shibui S; Takahashi M; Kawamoto M
    Diagn Pathol; 2016 Jul; 11(1):65. PubMed ID: 27449352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bevacizumab-Related Hyperintense Lesions on Diffusion-Weighted Imaging at Different Locations in a Patient with Malignant Glioma].
    Oshiro S; Wakuta N; Kawai S; Miki K; Shigemori Y
    No Shinkei Geka; 2017 Jun; 45(6):509-517. PubMed ID: 28634311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early assessment of recurrent glioblastoma response to bevacizumab treatment by diffusional kurtosis imaging: a preliminary report.
    Lee CY; Kalra A; Spampinato MV; Tabesh A; Jensen JH; Helpern JA; de Fatima Falangola M; Van Horn MH; Giglio P
    Neuroradiol J; 2019 Oct; 32(5):317-327. PubMed ID: 31282311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glioblastoma multiforme developing separately from the initial lesion 9 years after successful treatment for gliomatosis cerebri: a case report].
    Inoue T; Kanamori M; Sonoda Y; Watanabe M; Sasajima T; Kamisato N; Kumabe T; Tominaga T
    No Shinkei Geka; 2008 Aug; 36(8):709-15. PubMed ID: 18700534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudoprogression successfully treated with bevacizumab in a child with spinal pilocytic astrocytoma.
    Miyata K; Hori T; Shimomura Y; Joko M; Takayasu M; Okumura A
    Childs Nerv Syst; 2018 Nov; 34(11):2305-2308. PubMed ID: 29804214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan.
    Sathornsumetee S; Cao Y; Marcello JE; Herndon JE; McLendon RE; Desjardins A; Friedman HS; Dewhirst MW; Vredenburgh JJ; Rich JN
    J Clin Oncol; 2008 Jan; 26(2):271-8. PubMed ID: 18182667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the apparent diffusion coefficient in patients with recurrent glioblastoma under treatment with bevacizumab with radiographic pseudoresponse.
    Auer TA; Breit HC; Marini F; Renovanz M; Ringel F; Sommer CJ; Brockmann MA; Tanyildizi Y
    J Neuroradiol; 2019 Feb; 46(1):36-43. PubMed ID: 29733920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
    Shibahara I; Kumabe T; Kanamori M; Saito R; Sonoda Y; Watanabe M; Iwata R; Higano S; Takanami K; Takai Y; Tominaga T
    J Neurosurg; 2010 Aug; 113(2):358-68. PubMed ID: 19895196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal target point assessment for stereotactic biopsy in children with diffuse bithalamic astrocytomas.
    Messing-Jünger AM; Floeth FW; Pauleit D; Reifenberger G; Willing R; Gärtner J; Coenen HH; Langen KJ
    Childs Nerv Syst; 2002 Aug; 18(8):445-9. PubMed ID: 12192504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery for Recurrent High-Grade Glioma After Treatment with Bevacizumab.
    Blumenthal DT; Kanner AA; Aizenstein O; Cagnano E; Greenberg A; Hershkovitz D; Ram Z; Bokstein F
    World Neurosurg; 2018 Feb; 110():e727-e737. PubMed ID: 29183864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid malignant transformation of low-grade astrocytoma in a pregnant woman.
    Hanada T; Rahayu TU; Yamahata H; Hirano H; Yoshioka T; Arita K
    J Obstet Gynaecol Res; 2016 Oct; 42(10):1385-1389. PubMed ID: 27356501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Safety of Bevacizumab Administered Shortly after Laser Interstitial Thermal Therapy in Glioblastoma: A Case Series.
    Ali SC; Basil GW; Diaz RJ; Komotar RJ
    World Neurosurg; 2018 Sep; 117():e588-e594. PubMed ID: 29933086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pediatric case of anaplastic astrocytoma with a gliomatosis cerebri; the growth pattern and changes in serum VEGF-121 levels after bevacizumab treatment.
    Ninomiya H; Ozeki M; Matsuzawa Y; Nozawa A; Yasue S; Kubota K; Endo S; Asano T; Taguchi K; Ohe N; Matsuo M; Iwama T; Ohnishi H
    J Clin Neurosci; 2020 Nov; 81():431-433. PubMed ID: 33222957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin.
    Bennett IE; Field KM; Hovens CM; Moffat BA; Rosenthal MA; Drummond K; Kaye AH; Morokoff AP
    J Neurooncol; 2017 Jan; 131(2):321-329. PubMed ID: 27896520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect.
    McGirt MJ; Bulsara KR; Cummings TJ; New KC; Little KM; Friedman HS; Friedman AH
    J Neurosurg; 2003 Jan; 98(1):14-20. PubMed ID: 12546347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
    Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
    Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)-MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab.
    Leu K; Boxerman JL; Lai A; Nghiemphu PL; Pope WB; Cloughesy TF; Ellingson BM
    J Magn Reson Imaging; 2016 Nov; 44(5):1229-1237. PubMed ID: 26971534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric anaplastic astrocytoma in a child.
    Khongkhatithum C; Visudtibhan A; Chiemchanya S; Visudhiphan P; Sanvivad P; Larbcharoensub N; Phudhicharoenrat S
    J Clin Neurosci; 2007 Feb; 14(2):176-9. PubMed ID: 17161293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.